BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6965945)

  • 41. Immune regulation by polysaccharides: implications for skin cancer.
    Strickland FM
    J Photochem Photobiol B; 2001 Oct; 63(1-3):132-40. PubMed ID: 11684460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal cytoplasmic antigens: II. Concurrent presence of antigens of different specificities in normal human skin.
    Bystryn JC; Nash M; Robins P
    J Invest Dermatol; 1978 Aug; 71(2):110-3. PubMed ID: 79622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular immunity in squamous cell carcinoma of the uterine cervix.
    Levy S; Kopersztych S; Musatti CC; Souen JS; Salvatore CA; Mendes NF
    Am J Obstet Gynecol; 1978 Jan; 130(2):160-4. PubMed ID: 304309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
    Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
    Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
    [No Abstract]   [Full Text] [Related]  

  • 46. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.
    Baskies AM; Chretien PB; Weiss JF; Makuch RW; Beveridge RA; Catalona WJ; Spiegel HE
    Cancer; 1980 Jun; 45(12):3050-60. PubMed ID: 7388749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impairment of thymus-derived lymphoid cell function in patients with basal cell carcinoma.
    Dellon AL; Elfenbein GJ; Orlando JC
    J Surg Oncol; 1984 Feb; 25(2):92-7. PubMed ID: 6607384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-mediated immune response to basal cell carcinoma.
    Raffle EJ; MacLeod TM; Hutchinson F
    Acta Derm Venereol; 1981; 61(1):66-8. PubMed ID: 6164220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cross-reacting antigen common to stratified squamous epithelium and Streptococcus group A in tumors of epidermal origin].
    Silagadze DG; Beletskaia LV; Berenbein VA; Kolesnikova VIu
    Vopr Onkol; 1981; 27(6):27-32. PubMed ID: 7023039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune response against a human skin squamous cell carcinoma: humoral and cell-mediated immunity (author's transl)].
    Kondo S; Aso K
    Nihon Hifuka Gakkai Zasshi; 1980 Aug; 90(9):803-13. PubMed ID: 6968838
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of mononuclear cells infiltrating basal cell carcinomas.
    Claudy AL; Viac J; Schmitt D; Alario A; Thivolet J
    Acta Derm Venereol; 1976; 56(5):361-5. PubMed ID: 78620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T and B cells and cell-mediated immunity in mycosis fungoides.
    Nordqvist BC; Kinney JP
    Cancer; 1976 Feb; 37(2):714-8. PubMed ID: 130203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unique immunobiological aspects of head and neck squamous carcinoma.
    Chretien PB
    Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune evaluation of lung cancer patients undergoing radiation therapy.
    Stefani S; Kerman R; Abbate J
    Cancer; 1976 Jun; 37(6):2792-6. PubMed ID: 181124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.